Atlas Trials

Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment

Clinical trial NCT02297516 · COMPLETED

Trial details

NCT number
NCT02297516
Sponsor
Galderma R&D
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Aesthetics
Start date
2014-11-01
Primary completion
2017-03-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.